The technology provided herein generally relates to novel specific photoimmuno theranostics for the use in detection and elimination of skin cancer cells. The technology also relates to novel methods which generate homogeneous and specific photoimmuno theranostics reagents in a simple controlled and efficient way. This method combines molecular optical imaging photodynamic therapy and immunotherapy using SNAP tag technology.
